Journal profile · Medicine-Pediatrics, Perinatology and Child Health
Pediatric Hematology Oncology Journal
ISSN 2468-1245 · Elsevier · India
Pediatric Hematology Oncology Journal: diamond open access (no APC); no APC; review about 166 days (submission to acceptance, publisher); 326 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Pediatric Hematology Oncology Journal is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Acute Lymphoblastic Leukemia research, Neutropenia and Cancer Infections and Hemoglobinopathies and Related Disorders, together about 33% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of the Pediatric Hematology Oncology Chapter of the Indian Academy of PediatricsPHOJ aims to promote high quality research and disseminate scientific information in pediatric hematology and oncology. While its focus is typically low- and middle-income countries, particularly India, the journal also presents a platform for impactful research from all around the world to serve as a truly global publication. The journal publishes articles on pediatric hematology and pediatric oncology, onco-pathology, onco-radiology and allied subjects. The journal covers technical and clinical studies related to the above subjects including ethical and social issues. Articles with clinical interest and implications will be given preference.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pediatrics, Perinatology and Child Health
Editor-in-chief Vikramjit KanwarPublisher website
Editorial board by country: none in mainland China; most named India 22, United States 9, Singapore 4, United Kingdom 3, Hong Kong, China 1 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Lymphoblastic Leukemia researchMedicine18.2%
- Neutropenia and Cancer InfectionsMedicine7.7%
- Hemoglobinopathies and Related DisordersMedicine7%
- Lymphoma Diagnosis and TreatmentMedicine6.9%
- Hematopoietic Stem Cell TransplantationMedicine6.7%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology5.8%
- Sarcoma Diagnosis and TreatmentMedicine4.5%
- Acute Myeloid Leukemia ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pediatrics, Perinatology and Child Health | Q3 | 224/351 | 36th |
| Hematology | Q4 | 115/151 | 24th |
| Oncology | Q4 | 328/428 | 23rd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- CiteScore (publisher)
- 1.1Publisher website ·
- SJR 2026-06
- 0.22LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 29OpenAlex ·
- 2-year mean citedness
- 0.19OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 2,734 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 351 | 351 | 243 |
| 2025 | 326 | 326 | 288 |
| 2024 | 333 | 333 | 264 |
| 2023 | 309 | 309 | 233 |
| 2022 | 303 | 303 | 194 |
| 2021 | 203 | 203 | 137 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
166 dayssubmission to acceptance · community reports about 16 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to acceptance
- 166 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 26 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 600 / EUR 560 / GBP 480 / JPY 74,420 | — | — | |
| LetPub | No APC | Yes | — | |
| Publisher website | USD 600 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
Article types accepted15
- case reportWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- case seriesCase series should include 4 or more cases, usually up to 10 cases. Larger series with appropriate methodology and risk analysis may be considered original rese…Length not stated
- commentaryWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- editorialEssential elementsPatient's/Guardian's consent for research: Required for participants in clinical research. Please state “Informed consent was obtained from pa…Length not stated
- letterWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- letter to the editorIn reference to previously published manuscripts in PHOJ, titled: "Comment on: [Title of article being commented upon]"Length not stated
- meta-analysisWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- opinionWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- original researchWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- position statementIssued intermittently on topics that impact patient care by IAP-PHO members.Length not stated
- reviewWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
- review articleThe structure of longer articles is essentially similar (but please read carefully). The length for various articles will vary as listed below in table 2:Title:…Length not stated
- reviewsReviews focusing on the critical aspects of a subject, linking what is known to what areas remain unanswered.Length not stated
- short communicationShort communications can be personal opinions, or mini-review on a current topic, related to the journal's scope.Length not stated
- systematic reviewWe welcome original research, but contributions falling into any of categories below will be considered for publication. Authors contributing to special issues …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Generative AI and Figures, images and artwork
Please read our policy on the use of generative AI and AI-assisted tools in figures, images and artwork, which can be found in Elsevierʼs GenAI Policies for Journals. Thispolicy states:We do not permit the use of Generative AI or AI-assisted tools to create or alter images in submitted manuscripts.The only exception is if the use of AI or AI-assisted tools is part of the research design or methods…
Source ↗Publisher website ·- Authorship Author contributions: CRediT
Corresponding authors are encouraged to acknowledge co-author contributions using CRediT (Contributor Roles Taxonomy) roles: ConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationResourcesSoftwareSupervisionValidationVisualizationWriting – original draftWriting – review and editing Not all CRediT roles will apply to every manuscript and some …
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other funding Affiliation with the journal as an Editor or Advisory Boar…
Source ↗Publisher website ·- License & copyright Copyright
Permission of the society is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult editor.phoj@gmail.com). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.]
Source ↗Publisher website ·- Open access Open Access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer Review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors to determine suitability for publication in this journal. If your submission is deemed suitable, it will typically be sent to a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected will…
Source ↗Publisher website ·- Preprints Preprint references
Preprint sharing allowed Model summary
We ask you to mark preprints clearly. You should include the word "preprint" or the name of the preprint server as part of your reference and provide the preprint DOI. Where a preprint has subsequently become available as a peer-reviewed publication, use the formal publication as your reference. If there are preprints that are central to your work or that cover crucial developments in the topic, b…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- India
- Language
- English
- ISSN
- 2468-1245
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pediatric Hematology Oncology Journal
How long does peer review take at Pediatric Hematology Oncology Journal?
The publisher reports about 166 days (submission to acceptance); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pediatric Hematology Oncology Journal?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Reference style: Numbered, in order of citation; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pediatric Hematology Oncology Journal based?
Of the 45 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (22), United States (9) and Singapore (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Pediatric Hematology Oncology Journal?
According to LetPub and DOAJ records, Pediatric Hematology Oncology Journal is indexed in Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Pediatric Hematology Oncology Journal open access, and what is the APC?
Pediatric Hematology Oncology Journal is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .